Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Heico
HEI
5
Nova Minerals
NVA
CA Stock MarketDetailed Quotes
HBP Helix BioPharma Corp
- 0.960
- 0.0000.00%
15min DelayMarket Closed May 1 16:00 ET
50.90MMarket Cap-0.91P/E (TTM)
0.960High0.960Low3.07KVolume0.960Open0.960Pre Close2.95KTurnover1.35052wk High0.01%Turnover Ratio53.02MShares0.50052wk Low-1.05EPS TTM46.12MFloat Cap40.250Historical HighLossP/E (Static)48.04MShs Float0.300Historical Low-1.05EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Helix BioPharma Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 37.08%-940K | 53.51%-861K | 5.56%-5.22M | 51.46%-747K | 25.13%-1.13M | -36.81%-1.49M | -33.14%-1.85M | 15.09%-5.53M | 15.35%-1.54M | 7.10%-1.5M |
| Net income from continuing operations | -52.44%-1.38M | -6.54%-1.34M | -47.28%-9.26M | -145.03%-5.28M | -36.06%-1.83M | 23.88%-902K | 21.92%-1.25M | 4.16%-6.29M | -55.41%-2.15M | 0.00%-1.35M |
| Operating gains losses | 231.03%96K | 116.67%2K | 1,133.33%31K | 133.33%6K | 172.73%8K | --29K | -146.15%-12K | -133.33%-3K | -28.57%-18K | ---11K |
| Depreciation and amortization | -33.33%2K | 0.00%4K | 7.69%14K | -25.00%3K | 33.33%4K | 0.00%3K | 33.33%4K | 8.33%13K | 33.33%4K | 0.00%3K |
| Remuneration paid in stock | 66.67%35K | 82.35%62K | 517.75%3.52M | 772.22%3.45M | -82.35%6K | -82.93%21K | 112.50%34K | 33.88%569K | 1,031.43%396K | -57.50%34K |
| Other non cashItems | --0 | ---268K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 146.82%302K | 208.17%675K | 162.16%485K | 358.37%1.07M | 470.81%686K | -1,854.55%-645K | -467.06%-624K | 120.74%185K | 150.65%233K | 72.75%-185K |
| -Change in receivables | -66.67%2K | 357.14%18K | -96.31%8K | -33.33%34K | -212.50%-25K | 0.00%6K | -104.17%-7K | 193.24%217K | -27.14%51K | 73.33%-8K |
| -Change in prepaid assets | -381.82%-62K | 1,105.56%181K | -624.32%-194K | 65.00%-7K | -256.56%-191K | -15.38%22K | 80.22%-18K | 157.81%37K | 79.59%-20K | 165.22%122K |
| -Change in payables and accrued expense | 153.79%362K | 19.30%476K | 1,072.46%671K | -33.57%93K | 369.62%852K | -4,907.14%-673K | 329.03%399K | 92.35%-69K | 132.41%140K | 54.53%-316K |
| -Change in other current liabilities | --0 | --0 | ---- | ---- | 194.12%50K | --0 | ---998K | ---- | ---- | --17K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 37.08%-940K | 53.51%-861K | 5.56%-5.22M | 51.40%-748K | 25.20%-1.13M | -36.69%-1.49M | -33.24%-1.85M | 15.10%-5.53M | 15.39%-1.54M | 7.10%-1.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 9K | 166.67%8K | -180.00%-14K | -150.00%-2K | 0 | 0 | -100.00%-12K | -5K | 4K | 0 |
| Net PPE purchase and sale | --9K | 166.67%8K | -180.00%-14K | -150.00%-2K | --0 | --0 | -100.00%-12K | ---5K | --4K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --9K | 166.67%8K | -180.00%-14K | -150.00%-2K | --0 | --0 | -100.00%-12K | ---5K | --4K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 269,800.00%2.7M | 0 | 78.36%5.51M | 9.82%1.1M | 1.72M | 100.21%1K | 4.64%2.69M | -50.25%3.09M | -68.57%998K | 0 |
| Net issuance payments of debt | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---2.06M | --406K | --0 |
| Net common stock issuance | 269,800.00%2.7M | --0 | 32.64%5.51M | 369.95%1.1M | --1.72M | -99.98%1K | 561.58%2.69M | 38.64%4.15M | -4,411.11%-406K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --998K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 269,800.00%2.7M | --0 | 78.36%5.51M | 9.82%1.1M | --1.72M | 100.21%1K | 4.64%2.69M | -50.25%3.09M | -68.57%998K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -86.11%228K | 33.79%1.08M | -75.15%808K | -46.62%710K | -95.75%120K | -62.68%1.64M | -75.15%808K | -8.78%3.25M | -29.33%1.33M | 499.36%2.82M |
| Current changes in cash | 218.42%1.77M | -203.77%-853K | 111.17%273K | 164.43%346K | 139.76%598K | 5.15%-1.49M | -29.80%822K | -703.95%-2.44M | -139.60%-537K | -206.59%-1.5M |
| Effect of exchange rate changes | --0 | --0 | ---- | ---- | -172.73%-8K | ---28K | 142.31%11K | ---- | ---- | --11K |
| End cash Position | 1,563.33%2M | -86.11%228K | 33.79%1.08M | 33.79%1.08M | -46.62%710K | -95.75%120K | -62.68%1.64M | -75.15%808K | -75.15%808K | -29.33%1.33M |
| Free cash from | 36.95%-942K | 53.81%-861K | 5.47%-5.23M | 51.30%-750K | 25.20%-1.13M | -36.31%-1.49M | -33.52%-1.86M | 14.95%-5.54M | 15.34%-1.54M | 7.10%-1.5M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts